D Gupta, A Singh - Indian Journal of Psychological Medicine, 2024 - journals.sagepub.com
Background and Objective: United States Food and Drug Administration (USFDA) recently approved a novel combination of olanzapine-samidorphan (OLZSAM) for managing …
W Xu, G Gu, L Dong, L Wang - Journal of Healthcare …, 2022 - Wiley Online Library
The aim of this paper is to understand the current situation of the care burden of patients with mental illness in remission and the factors affecting it in order to provide a scientific basis for …
S Galderisi, GM Giordano - Schizophrenia research, 2022 - Elsevier
The current schizophrenia construct as delineated in the latest editions of the DSM and the ICD has some strengths, but also many weaknesses. It improved the reliability of the …
About a year and a half after publishing ICD-11, we aim to gather initial feedback, comments, opinions, and even recent study results from experts in the relevant fields …
Background There is conflicting evidence on impulsivity and its potential relationship with inhibitory control in schizophrenia. This study therefore aimed to identify differences in …
TL Bakken, M Sandberg, A Axmon - General psychiatry, 2024 - pmc.ncbi.nlm.nih.gov
Background The knowledge about the prevalence of schizophrenia among people with intellectual disabilities (ID) is sparse, particularly concerning the distribution in different age …
YT Park, D Han, KH Kim, H Kim, HJ Yoon, C Lane… - BMJ open, 2024 - bmjopen.bmj.com
Objectives This study aimed to evaluate the incidence of health insurance claims recording the cancer stage and TNM codes representing tumor extension size (T), lymph node …
A Cao, C Tang, X Chen, C Li - Preventive Medicine, 2023 - Elsevier
In this paper, we explore the characteristics of cognitive dysfunction in patients with schizophrenia complicated with metabolic syndrome (MS), and to explore the effects of …
A Chessa, O Sentissi - L'encephale, 2024 - Elsevier
Résumé Objectifs La mise à jour du chapitre sur les troubles mentaux, comportementaux et neurodéveloppementaux (MBND) de la Classification internationale des maladies (CIM-11) …